← JBS N.V.
| Annual Trend | FY 2018 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||
| NET INCOME (LOSS) | ($131.7m) | $2.0b | $2.2b | ||||
| Net Income From Continuing Operations | — | — | — | ($131.7m) | $2.0b | $2.2b | |
| Depreciation and amortization | — | — | — | $2.1b | $2.2b | $2.3b | |
| Depreciation Amortization Depletion | — | — | — | $2.1b | $2.2b | $2.3b | |
| Deferred Income Tax | — | — | — | ($128.0m) | $802.0m | $390.5m | |
| Deferred Tax | — | — | — | ($128.0m) | $802.0m | $390.5m | |
| Adjustments For Share-Based Payments | — | — | — | — | $15.8m | $28.9m | |
| Share-based compensation | — | — | — | $6.9m | $15.8m | $28.9m | |
| Asset Impairment Charge | — | — | — | $30.2m | $28.3m | $12.8m | |
| Adjustments For Income Tax Expense | — | — | — | — | $743.4m | $390.5m | |
| Earnings (Loss)es From Equity Investments | — | — | — | ($9.5m) | ($2.9m) | ($16.9m) | |
| Changes in operating assets and liabilities | — | — | — | ($74.2m) | ($1.4b) | ($2.9b) | |
| Additional Financial Items | |||||||
| Adjustments For Current Tax Of Prior Period | — | — | — | — | $759.0m | $632.0m | |
| Adjustments For Decrease Increase In Trade Account Receivable | — | — | — | — | ($333.6m) | ($347.3m) | |
| Adjustments For Finance Costs | — | — | — | — | $1.7b | $1.6b | |
| Adjustments For Increase Decrease In Trade Account Payable | — | — | — | — | $344.5m | $612.6m | |
| General And Administrative Expense | — | — | — | — | $2.3b | $2.2b | |
| Goodwill | — | — | — | — | $5.4b | $5.9b | |
| Interest Received Classified As Operating Activities | — | — | — | — | $192.2m | $188.4m | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | — | $417.8m | $432.5m | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | — | $3.0b | $10.1b | |
| Expected credit losses | — | — | — | $9.9m | $12.9m | $31.7m | |
| Share of profit of equity-accounted investees | — | — | — | ($9.5m) | ($2.9m) | ($16.9m) | |
| Gain on sales of assets | — | — | — | ($14.0m) | ($8.9m) | ($19.6m) | |
| Tax expense | — | — | — | ($128.0m) | $743.4m | $390.5m | |
| Net finance expense | — | — | — | $1.4b | $1.7b | $1.6b | |
| Provisions for legal proceedings | — | — | — | $106.1m | $47.2m | $189.4m | |
| Net realizable value inventory adjustments | — | — | — | ($6.1m) | $14.0m | $18.2m | |
| DOJ (Department of Justice) and antitrust agreements | — | — | — | $102.5m | $253.7m | $182.3m | |
| Fair value adjustment of biological assets | — | — | — | $85.0m | ($158.6m) | ($19.1m) | |
| Extemporaneous Litigation | — | — | — | — | $61.0m | $20.7m | |
| Trade accounts receivable | — | — | — | $624.8m | ($333.6m) | ($347.3m) | |
| Inventories | — | — | — | $480.5m | ($377.4m) | ($793.7m) | |
| Recoverable taxes | — | — | — | $137.7m | $45.4m | $54.0m | |
| Other current and non-current assets | — | — | — | ($40.9m) | ($7.6m) | ($123.6m) | |
| Biological assets | — | — | — | ($529.4m) | ($520.5m) | ($820.6m) | |
| Trade accounts payable and supply chain finance | — | — | — | ($787.0m) | $344.5m | $612.6m | |
| Other current and non-current liabilities | — | — | — | $249.5m | $62.4m | ($198.6m) | |
| DOJ and Antitrust agreements payment | — | — | — | ($90.3m) | ($170.6m) | ($402.8m) | |
| Interest received | — | — | — | $187.4m | $192.2m | $188.4m | |
| Purchases and disposals of intangible assets | — | — | — | ($9.0m) | ($10.6m) | ($7.1m) | |
| Acquisitions, net of cash acquired | — | — | — | ($3.5m) | ($5.8m) | — | |
| Related party transactions | — | — | — | $1.0m | $21.2m | ($53.9m) | |
| Others | — | — | — | $20.6m | — | ($39.3m) | |
| Cash used in investing activities | — | — | — | ($1.4b) | ($1.4b) | ($2.3b) | |
| Proceeds from loans and financing | — | — | — | $9.0b | $3.0b | $10.1b | |
| Payments of loans and financing | — | — | — | ($7.1b) | ($3.0b) | ($8.8b) | |
| Derivative instruments received (settled) | — | — | — | ($12.7m) | ($232.0m) | ($86.8m) | |
| Margin cash | — | — | — | ($26.6m) | $20.1m | ($16.6m) | |
| Dividends paid / Share premium distribution | — | — | — | ($448) | ($759) | ($2k) | |
| Payments of leasing contracts | — | — | — | ($428.7m) | ($417.8m) | ($432.5m) | |
| Cash provided by (used in) financing activities | — | — | — | $1.0b | ($1.4b) | ($1.8b) | |
| Non-cash additions to right of use assets and lease liabilities | — | — | — | $483.7m | $505.0m | $404.1m | |
| Capitalized interest | — | — | — | $68.2m | $31.7m | $35.0m | |
| Beginning Cash Position | — | — | — | $2.5b | $4.6b | $5.6b | |
| Cash Flow From Continuing Financing Activities | — | — | — | $1.0b | ($1.4b) | ($1.8b) | |
| Cash Flow From Continuing Investing Activities | — | — | — | ($1.4b) | ($1.4b) | ($2.3b) | |
| Change In Account Payable | — | — | — | ($787.0m) | $344.5m | $612.6m | |
| Change In Income Tax Payable | — | — | — | ($48.1m) | ($61.0m) | ($55.7m) | |
| Change In Inventory | — | — | — | ($48.8m) | ($898.0m) | ($1.6b) | |
| Change In Other Current Assets | — | — | — | ($40.9m) | ($7.6m) | ($123.6m) | |
| Change In Other Current Liabilities | — | — | — | $249.5m | $62.4m | ($198.6m) | |
| Change In Payable | — | — | — | ($835.1m) | $283.5m | $556.9m | |
| Change In Payables And Accrued Expense | — | — | — | ($835.1m) | $283.5m | $556.9m | |
| Change In Receivables | — | — | — | $762.4m | ($288.3m) | ($293.3m) | |
| Change In Tax Payable | — | — | — | ($48.1m) | ($61.0m) | ($55.7m) | |
| Change In Working Capital | — | — | — | $87.0m | ($848.0m) | ($1.7b) | |
| Changes In Account Receivables | — | — | — | $624.8m | ($333.6m) | ($347.3m) | |
| Changes In Cash | — | — | — | $2.0b | $1.4b | ($1.2b) | |
| End Cash Position | — | — | — | $4.6b | $5.6b | $4.6b | |
| Financing Cash Flow | — | — | — | $1.0b | ($1.4b) | ($1.8b) | |
| Free Cash Flow | — | — | — | $867.7m | $2.7b | $825.6m | |
| Gain Loss On Investment Securities | — | — | — | ($82.9m) | $502.6m | $217.4m | |
| Interest Received CFO | — | — | — | $187.4m | $192.2m | $188.4m | |
| Investing Cash Flow | — | — | — | ($1.4b) | ($1.4b) | ($2.3b) | |
| Issuance Of Capital Stock | — | — | — | $0 | $0 | — | |
| Net Business Purchase And Sale | — | — | — | ($3.5m) | ($5.8m) | ($185.7m) | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | ($57.5m) | ($138.4m) | ($77.8m) | |
| Net Intangibles Purchase And Sale | — | — | — | ($9.0m) | ($10.6m) | ($7.1m) | |
| Net PPE Purchase And Sale | — | — | — | ($1.4b) | ($1.4b) | ($2.0b) | |
| Operating Gains Losses | — | — | — | ($164.0m) | $352.5m | $103.2m | |
| Other Non Cash Items | — | — | — | $1.6b | $1.3b | $1.2b | |
| Provisionand Write Offof Assets | — | — | — | $116.0m | $60.1m | $238.2m | |
| Purchase Of Business | — | — | — | ($3.5m) | ($5.8m) | ($185.7m) | |
| Purchase Of Intangibles | — | — | — | ($9.0m) | ($10.6m) | ($7.1m) | |
| Purchase Of PPE | — | — | — | ($1.5b) | ($1.5b) | ($2.1b) | |
| Repurchase Of Capital Stock | — | — | — | $0 | ($7.6m) | ($600.0m) | |
| Sale Of PPE | — | — | — | $72.0m | $47.2m | $73.2m | |
| Stock Based Compensation | — | — | — | $6.9m | $15.8m | $28.9m | |
| Profit or Loss | — | — | — | — | $2.0b | $2.2b | |
| Total Adjustments | — | — | — | $3.6b | $6.9b | $6.9b | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | — | — | — | $72.0m | $47.2m | $73.2m | |
| Purchases of property, plant and equipment | — | — | — | ($1.5b) | ($1.5b) | ($2.1b) | |
| Net Other Investing Changes | — | — | — | $21.7m | $21.2m | ($99.8m) | |
| Cash flows from financing activities: | |||||||
| Issuance Of Debt | — | — | — | $9.0b | $3.0b | $10.1b | |
| Long Term Debt Issuance | — | — | — | $9.0b | $3.0b | $10.1b | |
| Net Issuance Payments Of Debt | — | — | — | $1.5b | ($431.8m) | $902.0m | |
| Net Long Term Debt Issuance | — | — | — | $1.5b | ($431.8m) | $902.0m | |
| Long Term Debt Payments | — | — | — | ($7.5b) | ($3.4b) | ($9.2b) | |
| Repayment Of Debt | — | — | — | ($7.5b) | ($3.4b) | ($9.2b) | |
| Common Stock Issuance | — | — | — | $0 | $0 | — | |
| Net Common Stock Issuance | — | — | — | $0 | ($7.6m) | ($600.0m) | |
| Common Stock Payments | — | — | — | $0 | ($7.6m) | ($600.0m) | |
| Dividends paid | — | — | — | — | $4 | — | |
| Payments of Dividends | — | — | — | — | $4 | — | |
| Dividends Paid Classified As Financing Activities | — | — | — | — | $759 | $2k | |
| Dividends received | — | — | — | $13 | $11 | $7 | |
| Dividends Prescribed and payable | — | — | — | $696k | $5k | $46k | |
| Cash Dividends Paid | — | — | — | ($448.0m) | ($759.3m) | ($1.6b) | |
| Common Stock Dividend Paid | — | — | — | ($448.0m) | ($759.3m) | ($1.6b) | |
| Dividends Received CFI | — | — | — | $12.6m | $10.7m | $7.3m | |
| Net Other Financing Charges | — | — | — | ($45.2m) | ($216.2m) | ($500.1m) | |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | $50.6m | ($352.9m) | $102.8m | |
| Effect Of Exchange Rate Changes | — | — | — | $50.6m | ($352.9m) | $102.8m | |
| Net change in cash and cash equivalents | — | — | — | $2.0b | $1.0b | ($1.0b) | |
| Cash and cash equivalents beginning of period | — | — | — | $4.6b | $5.6b | $4.6b | |
| Change In Cash Supplemental As Reported | — | — | — | $2.0b | $1.0b | ($1.0b) | |
| Interest Paid Classified As Operating Activities | — | — | — | ($5.9m) | $1.5b | $1.3b | |
| Income Taxes Paid Refund Classified As Operating Activities | — | — | — | ($70.9m) | $348.7m | $809.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.